“It gives clinicians objective clinical evidence guidance as to the risks and benefits of napping and catching up on sleep during weekends.” — Kaushik Govindaraju, DO, Medical Offices of Manhattan

“This guideline is a road map to help clinicians navigate these advances for the safest and most effective approaches to care.” — Mark A. Creager, MD, Dartmouth Health

“We show that following the guidelines as a whole benefits public health — a sustainable Nordic diet benefits public health and the climate.” — Christina Dahm, Associate Professor, Aarhus University

“It’s like a recipe—if you’re missing one ingredient, you may not obtain the same result.” — Pascal-André Vendittoli, MD, Université de Montréal

The working group strongly recommended inhaled corticosteroids (ICS) and streamlined management of asthma by suggesting a combination of ICS and rapid-onset long-acting β-agonist as both reliever and controller agents and step-up therapy by increasing ICS and/or adding long-acting anticholinergic agents.

The Wegovy tablet is the first oral GLP-1 receptor agonist indicated for weight loss and cardiovascular risk reduction in eligible adults.